Saturday, September 5, 2026

Digital banks using AI credit models grow 7x faster but face 10%+ delinquency spikes during regulatory shifts

Nu Holdings deployed its nuFormer AI underwriting model in 2025 and launched 100+ products, while Inter & Co added 7 million clients in its best year ever. When Brazil changed FGTS regulations in November 2025, Nu's portfolio growth dropped from 13-14% to 10%, exposing concentrated model risk in AI-driven lending.

Digital banks using AI credit models grow 7x faster but face 10%+ delinquency spikes during regulatory shifts
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Nu Holdings' nuFormer AI model went live in 2025, enabling the digital bank to launch over 100 products and features in a single year. Inter & Co welcomed 7 million new clients in 2025, its strongest annual performance, with newer customer cohorts transacting faster than older ones onboarded through traditional methods.

The speed advantage disappeared when external conditions shifted. Brazil's November 2025 FGTS regulation changes caused Nu's portfolio growth to slow from an expected 13-14% to roughly 10% within weeks. Inter projects its cost of risk will hit 5.5-6% in 2026, with private payroll loan delinquency climbing above 10%.

AI-native underwriting creates concentrated model risk because millions of customers are approved using identical algorithms trained on similar data. Traditional banks spread risk across multiple human underwriters making independent decisions with different risk tolerances and local knowledge.

Nu typically sees seasonal increases in 15-90 day non-performing loans during Q1, indicating vulnerability to predictable external shocks. The FGTS regulatory change represented an unpredictable shock that AI models trained on historical data couldn't anticipate.

Digital banks achieve faster customer acquisition because AI models process applications in seconds rather than days, require minimal documentation, and operate 24/7 without human review. Inter's 7 million new clients in one year would require thousands of loan officers using traditional methods.

The tradeoff manifests during downturns. When economic conditions or regulations change, AI models continue approving customers using pre-crisis patterns until delinquency data accumulates and triggers model retraining. Traditional underwriters adjust risk appetites immediately based on news and local economic signals.

Emerging markets amplify this dynamic because regulatory frameworks evolve rapidly and economic volatility exceeds developed markets. Brazil's consumer credit regulations changed three times in 2025, each time creating lag periods where AI models operated on outdated assumptions.

The financial impact is measurable: Nu's 3-4 percentage point growth slowdown on a multi-billion dollar portfolio represents hundreds of millions in reduced revenue. Inter's projected 10%+ delinquency rate on payroll loans will require significant loan loss provisions.

Banks now face a fundamental choice: accept slower growth with diversified underwriting risk, or chase AI-driven acquisition knowing regulatory changes and economic shocks will cause sharp delinquency spikes.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com